NCT05927532 - Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions

End Stage Renal Failure on Dialysis

Interventions

DEVICE

Argyle Safety Fistula Cannula with Anti-Reflux Valve

The Argyle Safety Fistula Cannula with Anti-reflux Valve will be used 3x a week for 12 weeks in subjects with an arteriovenous fistulae (AVF) fistula

Trial Locations (3)

DaVita Norfolk, Norfolk

DaVita Columbus, Columbus

DaVita Hartford, Hartford